Clinical Trial Update: Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing immunogenicity and safety of concomitant administration of RotaTeqV260 and DTP-IPV in healthy infants; completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Disease

Drugs mentioned

• Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV)
• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-04-09